Tag: Stephen Hanauer
-
Video of the Week – Dr. Stephen B. Hanauer on Mentoring Mentors
American College of Gastroenterology / Posts / Uncategorized / Video of the Week – Dr. Stephen B. Hanauer on Mentoring MentorsExplore the ACG Education Universe with Weekly Picks by Co-Editors
-
Featured Lectures at ACG 2019
*EMBARGOED All research presented at the 2019 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Monday, October…
-
David Y. Graham Lecture 2019
DAVID Y. GRAHAM LECTUREStephen B. Hanauer, MD, FACGMentoring Mentors Wednesday, October 30 | 10:20 am – 10:50 am | Stars…
-
Distinguished Career: Dr. Stephen B. Hanauer, 2018 Berk/Fise Clinical Achievement Awardee
American College of Gastroenterology / Posts / Uncategorized / Distinguished Career: Dr. Stephen B. Hanauer, 2018 Berk/Fise Clinical Achievement AwardeeDr. Hanauer Embodies the Spirit of the Berk/Fise Award ACG Past President Dr. Stephen B. Hanauer is this year’s Berk/Fise Clinical Achievement Awardee…
-
Featured Lectures at ACG 2018
*EMBARGOED All research presented at the 2018 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Monday, October…
-
J. Edward Berk Distinguished Lecture: Fake News and Alternative Facts on Personalized Medicine in IBD
American College of Gastroenterology / Posts / Uncategorized / J. Edward Berk Distinguished Lecture: Fake News and Alternative Facts on Personalized Medicine in IBDJ. EDWARD BERK DISTINGUISHED LECTURE Stephen B. Hanauer, MD, FACG Fake News and Alternative Facts on Personalized Medicine in IBD…
-
Looking Back, Looking Forward
As I devolve into Presidential dust, I have a few thoughts on my year, the ACG Annual Scientific Meeting, and…
-
A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study
American College of Gastroenterology / Posts / Uncategorized / A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE StudyOral 19 A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative…
-
ACG 2015 Prompts Reflections on My Year as President
American College of Gastroenterology / Posts / Expert Insights / ACG 2015 Prompts Reflections on My Year as PresidentOur Annual Scientific Meeting and Post Graduate Course October 16-21 in Honolulu, Hawaii, is fast approaching. The scientific program offers…
-
Being Mortal: A Personal Reflection
American College of Gastroenterology / Posts / Expert Insights / Being Mortal: A Personal ReflectionI just finished reading Atul Gawande’s Being Mortal: Medicine and What Matters in the End. It was not a spontaneous…